Bausch Health US., LLC. FDA Inspection Record

FEI 3010446985 · Inspections, Form 483s, warning letters and import refusals

Bausch Health US., LLC. is an FDA-inspected facility (FEI 3010446985) located in Bridgewater, NJ, US. RegDataLab tracks 8 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Nov 7, 2024: Voluntary Action Indicated (VAI)
Inspections on record
8 (3 VAI, 5 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
19, latest Feb 2, 2024
Import refusals
6

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 7, 2024Voluntary Action Indicated (VAI)Failure to comply with REMS Implementation System (FDCA 505-1(f)(4))
Apr 18, 2024No Action Indicated (NAI)No citations listed
Jun 16, 2021Voluntary Action Indicated (VAI)Failure to comply with REMS Implementation System (FDCA 505-1(f)(4))
May 16, 2019No Action Indicated (NAI)No citations listed
Feb 28, 2018No Action Indicated (NAI)No citations listed
May 17, 2016No Action Indicated (NAI)Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Failure to maintain records (21 CFR 314.80(j))
May 19, 2014Voluntary Action Indicated (VAI)Sponsors' general responsibilities (21 CFR 812.40)
Sponsor device shipment records inadequate (21 CFR 812.140(b)(2))
Other sponsor records required by FDA inadequate (21 CFR 812.140(b)(6))
No financial disclosure info in investigator agreement (21 CFR 812.43(c)(5))
and 3 more
Dec 24, 2013No Action Indicated (NAI)No citations listed

Recalls

Showing the 10 most recent of 19 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Feb 2, 2024Class IID-0355-2024Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains…
Subpotent Drug: Out of specification for assay
Jun 8, 2021Class IIID-0638-2021Mephyton (Phytonadione) 5 mg tablets, 100-count tablets, Rx Only, Manufactured for… and 1 more product
Failed Impurities/Degradation Specifications
Jan 7, 2021Class IIID-0243-2021Mephyton (phytonadione) Tablets 5mg, 100-count bottle, Rx Only, Manufactured for: Valeant… and 1 more product
Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.
Jul 13, 2020Class IID-0054-2021Hydrocortisone butyrate Cream, 0.1%, 15-gram tubes, Rx Only, Manufactured for Oceanside…
SUBPOTENT DRUG
Jan 30, 2019Class IIID-0487-2019Cardizem CD (diltiazem HCl) capsules, 120 mg, packaged in a) 30-count bottles (NDC… and 4 more products
Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain…
Aug 24, 2018Class IID-0084-2019Cortaid Intensive Therapy Cooling Spray (1% hydrocortisone), 2 FL OZ (59 mL) spray bottle… and 2 more products
CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility…
Jul 10, 2018Class IIID-1041-2018Diazepam Rectal Gel, 2.5 mg, TWIN PACK that Contains two pre-filled, unit-dose, rectal…
Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.
Jun 28, 2017Class IIID-0998-2017Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed…
Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete…
Mar 20, 2017Class IIID-0672-2017CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz. (148 mL), Valeant… and 1 more product
Discoloration.
Jun 10, 2016Class IIID-1059-2016SECONAL SODIUM (secobarbital sodium) Capsules, USP, 100 mg, 100 Ct. Bottles, Rx Only…
Labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis.

FDA record score

10 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

10 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAINov 7, 20246 x 0.63.6
Class II recall D-0355-2024, this FEI as the recalling firmFeb 2, 20244 x 0.62.4
Inspection classified VAIJun 16, 20216 x 0.251.5
Class II recall D-0054-2021, this FEI as the recalling firmJul 13, 20204 x 0.251
Class II recall D-0084-2019, this FEI as the recalling firmAug 24, 20184 x 0.251
Class II recall Z-0371-2016, this FEI as the recalling firmSep 14, 201510 years or older, so it adds no points0
Class II recall D-0163-2016, this FEI as the recalling firmSep 4, 201510 years or older, so it adds no points0
Class II recall D-1116-2015, this FEI as the recalling firmApr 17, 201510 years or older, so it adds no points0
Class II recall D-0379-2015, this FEI as the recalling firmDec 31, 201410 years or older, so it adds no points0
Inspection classified VAIMay 19, 201410 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Bausch Health US., LLC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Bausch Health US., LLC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Bausch Health US., LLC.
Location
Bridgewater, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.